Literature DB >> 30504297

Treatment approach for young, fit, newly diagnosed multiple myeloma patients.

Saad Z Usmani1, Eric Seifter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30504297      PMCID： PMC6246032          DOI： 10.1182/asheducation-2018.1.97

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN： 1520-4383


× No keyword cloud information.
  32 in total

1.  Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.

Authors:  Sarah Waheed; Alan Mitchell; Saad Usmani; Joshua Epstein; Shmuel Yaccoby; Bijay Nair; Rudy van Hemert; Edgardo Angtuaco; Tracy Brown; Twyla Bartel; James McDonald; Elias Anaissie; Frits van Rhee; John Crowley; Bart Barlogie
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

2.  Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

Authors:  Rajshekhar Chakraborty; Eli Muchtar; Shaji K Kumar; Francis K Buadi; David Dingli; Angela Dispenzieri; Suzanne R Hayman; William J Hogan; Prashant Kapoor; Martha Q Lacy; Nelson Leung; Rahma Warsame; Taxiarchis Kourelis; Wilson Gonsalves; Morie A Gertz
Journal:  Br J Haematol       Date:  2018-04-29       Impact factor: 6.998

3.  Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

Authors:  Elena Zamagni; Francesca Patriarca; Cristina Nanni; Beatrice Zannetti; Emanuela Englaro; Annalisa Pezzi; Paola Tacchetti; Silvia Buttignol; Giulia Perrone; Annamaria Brioli; Lucia Pantani; Carolina Terragna; Francesca Carobolante; Michele Baccarani; Renato Fanin; Stefano Fanti; Michele Cavo
Journal:  Blood       Date:  2011-09-06       Impact factor: 22.113

4.  Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

Authors:  Philip L McCarthy; Sarah A Holstein; Maria Teresa Petrucci; Paul G Richardson; Cyrille Hulin; Patrizia Tosi; Sara Bringhen; Pellegrino Musto; Kenneth C Anderson; Denis Caillot; Francesca Gay; Philippe Moreau; Gerald Marit; Sin-Ho Jung; Zhinuan Yu; Benjamin Winograd; Robert D Knight; Antonio Palumbo; Michel Attal
Journal:  J Clin Oncol       Date:  2017-07-25       Impact factor: 44.544

5.  Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

Authors:  Meletios A Dimopoulos; Jens Hillengass; Saad Usmani; Elena Zamagni; Suzanne Lentzsch; Faith E Davies; Noopur Raje; Orhan Sezer; Sonja Zweegman; Jatin Shah; Ashraf Badros; Kazuyuki Shimizu; Philippe Moreau; Chor-Sang Chim; Juan José Lahuerta; Jian Hou; Artur Jurczyszyn; Hartmut Goldschmidt; Pieter Sonneveld; Antonio Palumbo; Heinz Ludwig; Michele Cavo; Bart Barlogie; Kenneth Anderson; G David Roodman; S Vincent Rajkumar; Brian G M Durie; Evangelos Terpos
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

Review 6.  The molecular characterization and clinical management of multiple myeloma in the post-genome era.

Authors:  Y Zhou; B Barlogie; J D Shaughnessy
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

Review 7.  Defining and treating high-risk multiple myeloma.

Authors:  S Z Usmani; P Rodriguez-Otero; M Bhutani; M-V Mateos; J S Miguel
Journal:  Leukemia       Date:  2015-08-12       Impact factor: 11.528

8.  Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Authors:  Antonio Palumbo; Hervé Avet-Loiseau; Stefania Oliva; Henk M Lokhorst; Hartmut Goldschmidt; Laura Rosinol; Paul Richardson; Simona Caltagirone; Juan José Lahuerta; Thierry Facon; Sara Bringhen; Francesca Gay; Michel Attal; Roberto Passera; Andrew Spencer; Massimo Offidani; Shaji Kumar; Pellegrino Musto; Sagar Lonial; Maria T Petrucci; Robert Z Orlowski; Elena Zamagni; Gareth Morgan; Meletios A Dimopoulos; Brian G M Durie; Kenneth C Anderson; Pieter Sonneveld; Jésus San Miguel; Michele Cavo; S Vincent Rajkumar; Philippe Moreau
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

9.  Gene signature combinations improve prognostic stratification of multiple myeloma patients.

Authors:  W J Chng; T-H Chung; S Kumar; S Usmani; N Munshi; H Avet-Loiseau; H Goldschmidt; B Durie; P Sonneveld
Journal:  Leukemia       Date:  2015-12-16       Impact factor: 11.528

10.  Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.

Authors:  Nikhil C Munshi; Herve Avet-Loiseau; Andy C Rawstron; Roger G Owen; J Anthony Child; Anjan Thakurta; Paul Sherrington; Mehmet Kemal Samur; Anna Georgieva; Kenneth C Anderson; Walter M Gregory
Journal:  JAMA Oncol       Date:  2017-01-01       Impact factor: 31.777
View more
  3 in total

1.  Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.

Authors:  Amelie Boquoi; Veronika Rings; Annemarie Mohring; Ingrida Savickaite; Romans Zukovs; Judith Strapatsas; Kathrin Nachtkamp; Guido Kobbe; Ulrich Germing; Roland Fenk
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 2.  Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

Authors:  Evangelos Terpos; Joseph Mikhael; Roman Hajek; Ajai Chari; Sonja Zweegman; Hans C Lee; María-Victoria Mateos; Alessandra Larocca; Karthik Ramasamy; Martin Kaiser; Gordon Cook; Katja C Weisel; Caitlin L Costello; Jennifer Elliott; Antonio Palumbo; Saad Z Usmani
Journal:  Blood Cancer J       Date:  2021-02-18       Impact factor: 11.037

3.  Front-line treatment of multiple myeloma.

Authors:  Michele Cavo; Paola Tacchetti; Elena Zamagni
Journal:  Hemasphere       Date:  2019-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.